Analytical validation of a microplate reader-based method for the therapeutic drug monitoring of l-asparaginase in human serum

This publication has 27 references indexed in Scilit:

• L-asparagine depletion and L-asparaginase activity in children with acute lymphoblastic leukemia receiving i.m. or i.v. Erwinia C. or E. coli L-asparaginase as first exposure
  Annals of Oncology, 2000
• Pharmacokinetic dose adjustment of Erwinia asparaginase in protocol II of the paediatric ALL/NHL‐BFM treatment protocols
  British Journal of Haematology, 1999
• Use of ?-asparaginase in childhood ALL
  Critical Reviews in Oncology/Hematology, 1998
• Dose reduction of asparaginase under pharmacokinetic and pharmacodynamic control during induction therapy in children with acute lymphoblastic leukaemia
  British Journal of Haematology, 1997
• Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations
  European Journal Of Cancer, 1996
• Comparative pharmacokinetic studies of three asparaginase preparations.
  Journal of Clinical Oncology, 1993
• L-Asparaginase and PEG Asparaginase— Past, Present, and Future
  Leukemia & Lymphoma, 1993
• Non‐randomised study comparing toxicity of escherichia coli and erwinia asparaginase in children with leukaemia
  Medical and Pediatric Oncology, 1990
• Increased antithrombin III concentration in children with acute lymphatic leukaemia receiving L-asparaginase therapy
  Medical and Pediatric Oncology, 1988
• Ein neuer Nachweis von Hydroxylamin durch Bildung von Chinolinchinon‐(5.8)‐[8‐oxy‐chinolyl 5‐imid] ‐(5), genannt „Indo‐oxin”︁
  Berichte der deutschen chemischen Gesellschaft (A and B Series), 1940